The company reiterated that the ASPEN-Breast Phase II trial is "on track to dose its first patient this quarter," with interim data expected in Q3 2026. ALX2004 initial safety data is expected in the ...
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline ...
ALX Oncology Holdings (NASDAQ:ALXO) is set to give its latest quarterly earnings report on Friday, 2025-11-07. Here's what investors need to know before the announcement. Analysts estimate that ALX ...
Alexander’s (ALX) posted a net profit margin of 17.1%, down from 22.1% in the prior year, with earnings declining 2.5% per year over the past five years and negative earnings growth in the most recent ...
Google, in collaboration with ICT skills training provider ALX, last week hosted the annual Google South Africa Hardware Hackathon at AI Expo Africa, showcasing data centre operations talent on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback